Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

During the Trading Day
161.08 -3.23 / -1.97%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
161.11 +0.0322 / +0.02%
Volume: 12.4K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line175.3M254.8M252.9M656.9M
Total Other Cash Flow52.3M82.0M120.4M-67.3M
Funds From Operations287.3M431.9M493.4M482.6M
Funds From/For Other Operating Expenses17.2M21.3M-3.9M-157.4M
Net Cash Flow - Operating Activities270.1M410.6M497.3M640.1M
InvestingIncrease In Investments0.000.00-1.0B-667.7M
Decrease In Investments94.5M0.0060.9M619.4M
Capital Expenditures-22.0M-21.8M-29.3M-136.7M
Net Assets From Acquisitions -105.9M-605.7M0.000.00
Other Investing - Uses-307.0K-4.0K-9.3M-507.0K
Net Cash Flow Investing-33.7M-627.6M-1.0B-222.9M
FinancingShort Term Borrowings0.
Long Term Borrowings60.0M348.8M0.000.00
Long Term Debt Reduction-60.7M-206.0M-36.0M-55.5M
Net Proceeds Stock Sale35.8M528.7M71.3M114.4M
Common Preferred Redeemed0.00-11.6M-66.1M-302.6M
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing4.0M7.2M105.7M251.1M
Other Uses - Financing0.00765.0K3.2M261.0K
Net Cash Flow - Financing39.1M666.4M71.6M7.1M
Exchange RateEffect of Exchange Rate on Cash-1.7M-768.0K-1.5M-10.2M
Net Change In Cash275.4M449.4M-458.2M424.3M